DOCSLIB.ORG

Instruction Manual Part 2B 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Instruction Manual Part 2B 2011 TABLE OF CONTENTS Page SECTION I – INTRODUCTION A. Introduction ........................................................................................ 1 Major Revisions from Previous Manuals ............................................. 4 B. Medical Certification .......................................................................... 7 Excerpt from U.S. Standard Certificate of Death ................................ 8 U.S. Standard Certificate of Death ....................................................... 9 SECTION II – GENERAL INSTRUCTIONS A. Introduction......................................................................................... 12 1. Excessive Codes ........................................................................... 12 2. Created Codes .............................................................................. 14 3. “Dagger and asterisk” codes ........................................................ 25 B. General coding concept ..................................................................... 26 1. Definitions and types of diagnostic entities .................................. 26 a. One-term entity ........................................................................ 26 b. Multiple one-term entity .......................................................... 28 c. Adjectival modifier reported with multiple conditions ........... 30 2. Parenthe tical entries ...................................................................... 31 3. Special diagnostic entities ............................................................. 32 4. Plural form of disease .................................................................... 33 5. Implie d “disease” .......................................................................... 33 6. Non-trauma tic conditions .............................................................. 33 7. Drug dependent, drug dependency ................................................ 34 C. Format.................................................................................................. 35 1. “Due to” relationships involving more than four causally related conditions .................................................... 35 2. Connec ting terms .......................................................................... 35 a. “Due to” written in or implied ................................................. 35 b. Not indicating a “due to” relationship ..................................... 35 3. Condition entered above line I(a) ................................................. 38 4. Condition reported between lines in Part I ................................... 39 5. Condition reported as due to I(a), I(b), or I(c) .............................. 40 6. Conditions reported in Part II ........................................................ 41 7. Deletion of “due to” on the death certificate ................................ 41 8. Deletion of “Part II” on death certificate ...................................... 42 9. Numbering of causes reported in Part I ........................................ 43 10. Punctu ation marks ......................................................................... 44 11. Conditions in the duration box ...................................................... 46 i 2b January 2011 Instruction Manual Part 2b Table of Contents (continued) D. Doubtful diagnosis .............................................................................. 47 1. Doubtful qualifying expression ..................................................... 47 2. Interpretation of “either…or…” .................................................... 48 E. Conditions specified as “healed” or “history of” ............................. 51 F. Coding entries such as “same,” “ditto ("),” “as above”.................. 52 G. Conditions qualified by “postmortem, ” “rule out,” “ruled out,” “r/o” .......................................................................... 53 H. Nonindexed and illegible entries........................................................ 54 1. Terms that are not indexed ............................................................ 54 2. Illegible entries .............................................................................. 54 I. Coding one-character reject codes .................................................... 55 1. Reject code 1-5 – Inconsistent duration ........................................ 55 2. Reject code 9 – More than four “due to” statements .................... 57 J. Inclusion of additional information (AI) to mortality source documents........................................................................... 58 K. Amended certificates ......................................................................... 61 L. Effect of age of decedent on classification ........................................ 62 1. NEWBORN OR NEONATAL means less than 28 days of age at the time of death ..................................................... 62 2. INFANT OR INFANTILE means less than 1 year of age at the time of death .................................................................... 62 3. CHILD or CHILDHOOD means less than 18 years of age at the time of death .................................................................... 63 4. Congenital anomalies (Q00-Q99) ................................................. 63 a. Less than 28 days .................................................................. 63 b. Less than 1 year ..................................................................... 63 5. Congenital syphilis ........................................................................ 64 6. Age limitation ................................................................................ 65 M. Sex limitations ..................................................................................... 67 N. Effect of duration on assignment of codes........................................ 68 1. Qualifying conditions as acute or chronic .................................... 68 2. Subacute ........................................................................................ 69 3. Exacerbation .................................................................................. 70 4. Acute and chronic ......................................................................... 70 5. Qualifying conditions as congenital or acquired .......................... 71 6. Two conditions with one duration ................................................ 71 7. Conflict in durations ...................................................................... 72 8. Span of dates ................................................................................. 72 ii 2b January 2011 Instruction Manual Part 2b Table of Contents (continued) O. Relating and modifying conditions.................................................... 73 1. Implied site of disease ................................................................... 73 a. General instructions for implied site of a disease. ................... 73 b. Relating specific categories .................................................... 76 c. Exceptions to relating and modifying instructions .................. 78 2. Coding conditions classified to injuries as disease conditions ..... 80 SECTION III – INTENT OF CERTIFIER........................................................ 84 1. Other and unspecified gastroenteritis and colitis of unspecified origin (A090) ........................................................................................ 85 2. Spinal Abscess (A180) .......................................................................... 86 3. Charcot’s Arthropathy (A521) .............................................................. 87 4. General Paresis (A521) ......................................................................... 88 5. Viral Hepatitis (B161, B169, B171-B178) ........................................... 90 6. Organisms and Infection NOS (B99) ................................................... 91 7. Eaton-Lambert Syndrome (C80) .......................................................... 97 8. Erythrem ia (C940) ................................................................................ 97 9. Polycythem ia (D45) .............................................................................. 98 10. Hemolytic Anemia (D589) ................................................................... 99 11. Sideroblastic Anemia (D643) ............................................................... 100 12. Hemorrhagic Purpura NOS (D693) ...................................................... 101 13. Thrombocytope nia (D696) ................................................................... 102 14. Hyperparathyr oidism (E213) ................................................................ 104 15. Hyperaldosteronism (E269) .................................................................. 105 16. Lactase Deficiency (E730) .................................................................... 106 17. Korsakov’s Disease, Psychosis, or Syndrome (F106) .......................... 107 18. Drug Use NOS - Named Drug Use (F11-F16, F18-F19) ..................... 108 19. Tobacco Use (F179) .............................................................................. 111 20. Psychotic Episode NOS (F239) ............................................................ 112 21. Psychosis (any F29) .............................................................................. 113 22. Dissociative Disorder (F449) ...............................................................
Load more

Recommended publications
  • Emergency Medical Services Program Policies – Procedures – Protocols
    Emergency Medical Services Program Policies – Procedures – Protocols Protocols Table of Contents GENERAL PROVISIONS ................................................................................................ 3 DESTINATION DECISION SUMMARY-METRO BAKERSFIELD AREA ........................ 5 DETERMINATION OF DEATH ..................................................................................... 12 101 AIRWAY OBSTRUCTION ...................................................................................... 16 102 ALTERED LEVEL OF CONSCIOUSNESS ............................................................ 18 103 ALLERGIC REACTION/ANAPHYLAXIS ................................................................ 20 104 ASYSTOLE/ PULSELESS ELECTRICAL ACTIVITY ............................................. 22 105 BITES STINGS ENVENOMATION ......................................................................... 24 106 BRADYCARDIA ..................................................................................................... 26 107 BRIEF RESOLVED UNEXPLAINED EVENT ......................................................... 29 108 BURNS ................................................................................................................... 32 109 CHEMPACK ........................................................................................................... 35 110 CHEST PAIN OR ACUTE CORONARY SYNDROME ........................................... 37 111 CHEST TRAUMA ..................................................................................................
    [Show full text]
  • Critical Care Nursing of Infants and Children Martha A
    University of Pennsylvania ScholarlyCommons Miscellaneous Papers Miscellaneous Papers 1-1-2001 Critical Care Nursing of Infants and Children Martha A. Q. Curley University of Pennsylvania, [email protected] Patricia A. Moloney-Harmon The Children's Hospital at Sinai Copyright by the author. Reprinted from Critical Care Nursing of Infants and Children, Martha A.Q. Curley and Patricia A. Moloney-Harmon (Editors), (Philadelphia: W.B. Saunders Co., 2001), 1,128 pages. NOTE: At the time of publication, the author, Martha Curley was affiliated with the Children's Hospital of Boston. Currently, she is a faculty member in the School of Nursing at the University of Pennsylvania. This paper is posted at ScholarlyCommons. http://repository.upenn.edu/miscellaneous_papers/4 For more information, please contact [email protected]. Please Note: The full version of this book and all of its chapters (below) can be found on ScholarlyCommons (from the University of Pennsylvania) at http://repository.upenn.edu/miscellaneous_papers/4/ Information page in ScholarlyCommons Full book front.pdf - Front Matter, Contributors, Forward, Preface, Acknowledgements, and Contents Chapter 1.pdf - The Essence of Pediatric Critical Care Nursing Chapter 2.pdf - Caring Practices: Providing Developmentally Supportive Care Chapter_3.pdf - Caring Practices: The Impact of the Critical Care Experience on the Family Chapter_4.pdf - Leadership in Pediatric Critical Care Chapter 5.pdf - Facilitation of Learning Chapter_6.pdf - Advocacy and Moral Agency: A Road Map for
    [Show full text]
  • Barbiturate Blood Levels Found at Necropsy in Proven Cases of Acute Barbiturate Poisoning
    J. clin. Path., 1970, 23, 435-439 J Clin Pathol: first published as 10.1136/jcp.23.5.435 on 1 July 1970. Downloaded from Barbiturate blood levels found at necropsy in proven cases of acute barbiturate poisoning ROGER GILLETT AND FRANK G. WARBURTON From the Department ofPathology, Hope Hospital, Salford, Lancs SYNOPSIS In order to determine whether blood barbiturate levels could be used to ascertain that death had been caused by barbiturate overdose, samples of blood from 128 subjects of coroners' necropsies were examined for barbiturate content. Sixty of these were well authenti- cated cases of barbiturate overdosage, and barbiturates were implicated, together with other factors such as alcohol and carbon monoxide, in a further 16 cases. The remaining 52 cases were of an eliminatory nature, 10 of which had low barbiturate blood levels considered to be within the therapeutic range. The results indicate that when the accepted levels producing loss of consciousness are exceeded, and maintained, death will ensue if treatment is not given. These results may be of value in assessing findings in necropsies requested by the coroner, and are in no way applicable to the living patient in whom it is well established that recovery from higher blood levels http://jcp.bmj.com/ may take place if adequate treatment is available. Anatomical evidence of barbiturate poisoning but he notes that it must not be inferred that on September 23, 2021 by guest. Protected copyright. at necropsy is not specific, often amounting only finding these levels constitutes prima facie to signs of asphyxia. The presence of powder evidence of death from barbiturate poisoning.
    [Show full text]
  • Clinical Toxicology J.A
    Postgrad Med J: first published as 10.1136/pgmj.69.807.19 on 1 January 1993. Downloaded from Postgrad Med J (1993) 69, 19 - 32 A) The Fellowship of Postgraduate Medicine, 1993 Reviews in Medicine Clinical toxicology J.A. Vale Director, National Poisons Information Service (Birmingham Centre), West Midlands Poisons Unit and Pesticide Monitoring Unit, Dudley Road Hospital, Birmingham B18 7QH, UK Introduction Selfpoisoning is the second most common cause of Much of the relevant literature relates to studies in acute medical presentation to hospital in the UK. volunteers given either a non-toxic marker or a However, as a result ofchanges over the last decade non-toxic dose ofa drug. As a result, the extrapola- both in the amount and type of agent ingested, the tion of many of these data to the poisoned patient majority of patients now suffer little if any adverse cannot be done with confidence. consequence and so require no active medical intervention. Nonetheless, a substantial minority Gastric lavage ofpoisoned patients do still require skilled medical management, often using the facilities of an inten- Although 'the idea of washing out the stomach sive care unit, if they are to survive without any with a syringe and tube, in cases where large important sequelae. Supportive therapy, including quantities oflaudanum and other poisons had been the correction of metabolic abnormalities, is of swallowed,' was first reported by Physick' in 1812 paramount importance in the care of such severely the value of gastric lavage remains controversial. by copyright. poisoned patients and this approach alone has Lavage performed 60 minutes after a therapeutic reduced the mortality significantly.
    [Show full text]
  • 2020 Emr Summary
    2020 EMR SUMMARY EMR Well Being Body substance isolation Immunizations Proper lifting techniques Proper precautions at haz-mat scenes EMR response to death or serious injury may lead to critical incident stress. Defusing- an early intervention that occurs at the scene or shortly after the scene of an incident, designed to stop the negative stress process that may occur in the hours immediately following a disaster response. Critical incident stress debriefing (CISD)-A psychological, emotional and educational group process to diminish the impact of critical incident stress Medical/Legal & Ethical Issues Golden Rule “Do unto others as you would have others do unto you” Public Health Law Article 30, Part 800 This contains the rules & regulations in reference to EMS & immunities. An EMR cannot be held liable unless gross negligence can be proven. GOOD SAMARITAN ACT (does not cover EMR in NYS) It is designed to protect private non - certified persons who assist in emergency treatment from legal action, with the exception of gross negligence. Staying within the scope of practice & standard of care for his/her level of training, combined with proper documentation will go a long way in preventing the EMR from being involved in litigation. NEGLIGENCE Deviation from the standard of care as recognized by law Criteria: Duty to act – An obligation to provide care to a patient Breech of duty Injury occurred Proximate cause – Injury resulted from improper action or failure to act. ASSAULT & BATTERY- In certain circumstances the EMR can be charged with assault & battery for treating an adult without consent. Assault verbal Battery Physical 1 Nassau County Fire Police EMS Academy NCPD EMR Summary Rev.
    [Show full text]
  • Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: a Case Report Chaudhry Adeel Ebad1*, Alan Gaffney2 and Peter J Conlon1
    ISSN: 2572-3286 Ebad et al. J Clin Nephrol Ren Care 2018, 4:034 DOI: 10.23937/2572-3286.1510034 Volume 4 | Issue 1 Journal of Open Access Clinical Nephrology and Renal Care CASE REPORT Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: A Case Report Chaudhry Adeel Ebad1*, Alan Gaffney2 and Peter J Conlon1 1 Department of Nephrology, Beaumont Hospital, Ireland Check for updates 2Department of Anesthesia and Intensive Care Unit, Beaumont Hospital, Ireland *Corresponding author: Chaudhry Adeel Ebad, Department of Nephrology, Beaumont Hospital, Dublin 9, Ireland, E-mail: [email protected] known time. He was brought unconscious had GCS of 3 Abstract blood pressure 120/75 pulse 85 per minutes’ respirato- We report affective utilization of continuous veno-venous ry rate 12 per minutes’ and temperature of 36.5 °C was hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamical- intubated and ventilated and transferred to intensive ly stable. Historically treatment includes supportive care, care unit. His medical background history includes bipo- activated charcoal and urinary alkalinisation along with the lar disorder, deliberate self harm. application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-ve- His initial investigation showed positive blood and nous hemodiafiltration are affective treatment for removal urine toxicology screen for barbiturates only and phe- of drug. Early initiation of extracorporeal treatment and in- nobarbital level of 160.5 mg/L, others investigation in- creasing blood flow rate effectively reduced half life of drug cluding full blood count, renal profile, liver function, ar- and improved patient outcome with fatal poisoning.
    [Show full text]
  • Sedative Hypnotics Leon Gussow and Andrea Carlson
    CHAPTER 165 Sedative Hypnotics Leon Gussow and Andrea Carlson BARBITURATES three times therapeutic, the neurogenic, chemical, and hypoxic Perspective respiratory drives are progressively suppressed. Because airway reflexes are not inhibited until general anesthesia is achieved, Barbiturates are discussed in do-it-yourself suicide manuals and laryngospasm can occur at low doses. were implicated in the high-profile deaths of Marilyn Monroe, Therapeutic oral doses of barbiturates produce only mild Jimi Hendrix, Abbie Hoffman, and Margaux Hemingway as well decreases in pulse and blood pressure, similar to sleep. With toxic as in the mass suicide of 39 members of the Heaven’s Gate cult in doses, more significant hypotension occurs from direct depression 1997. Although barbiturates are still useful for seizure disorders, of the myocardium along with pooling of blood in a dilated they rarely are prescribed as sedatives, with the availability of safer venous system. Peripheral vascular resistance is usually normal or alternatives, such as benzodiazepines. Mortality from barbiturate increased, but barbiturates interfere with autonomic reflexes, poisoning declined from approximately 1500 deaths per year in which then do not adequately compensate for the myocardial the 1950s to only two fatalities in 2009.1 depression and decreased venous return. Barbiturates can precipi- Barbiturates are addictive, producing physical dependence and tate severe hypotension in patients whose compensatory reflexes a withdrawal syndrome that can be life-threatening. Whereas tol- are already maximally stimulated, such as those with heart failure erance to the mood-altering effects of barbiturates develops or hypovolemic shock. Barbiturates also decrease cerebral blood rapidly with repeated use, tolerance to the lethal effects develops flow and intracerebral pressure.
    [Show full text]
  • Stg Health Center
    STNDARD TREATMENT GUIDELINE FOR HEALTH CENTERS Drug Administration and Control Authority of Ethiopia Contents January 2010 1 Contents Acknowledgments …………… ….……………………………………………………………….. viii Abbreviations ………………………..…………………………………………………………….. xi Forward …………………………………..…………………………………………………………… xii Introduction ……………………………..………………………………………………………….. xiii General Guidance ………………………………………………………………………………… xiv How to USE the STG ……………………………………………………………………………… xxviii Chapter I INFECTIOUS DISEASES………………………………………………………………………… 111 Acquired Immunodeficincy Syndrome…………………………….……………………… 2 Amebiasis …………………………………………………………………………..……………….. 12 Amebic liver Abscess ……………………………………………………………………………. 13 Bacillary Dysentry …………………………………………………….………………………….. 14 Bronchitis (Acute) ……………………………………………………..………………………….. 15 Brucellosis …………………………………………………………………..………………………. 17 Cholera ………………………………………………………………………..……………………… 18 Gastroenteritis ……………………………………………………………………..……………… 20 Giardiasis …………………………………………………………………………..……………….. 21 Intestinal Parasitic Infestations ……………………………………………………………. 21 Leishmaniasis …………………………………………………………………………………..…. 25 Leprosy ……………………………………………………………………………………………….. 27 Malaria ……………………………………………………………………………………………….. 30 Meningitis …………………………………………………………………………………………… 33 Onchocerciasis ………………………………………….…………………………………………. 38 Pneumonia …………………………………………………………………………………………. 39 Relapsing Fever …………………………………………………………………………………… 41 Schistosomiasis ………………………………………………………….……………………….. 42 Tuberculosis ………………………………………………………………………………………… 42 Typhoid Fever……………………………………………………………………………………….
    [Show full text]
  • Facts About Drugs: Sedative Hypnotics
    SEDATIVE - HYPNOTICS stop using large doses of these drugs suddenly, they may What are sedative-hypnotics? What are barbiturates? develop physical withdrawal symptoms ranging from Sedative-hypnotics are drugs which depress or slow Barbiturates are often called “barbs” and “downers”. restlessness, insomnia and anxiety, to convulsions and down the body’s functions. Often these drugs are Barbiturates that are commonly abused include death. When users become psychologically dependent, referred to as tranquilizers and sleeping pills or amobarbital (Amytal), pentobarbital (Nembutal), and they feel as if they need the drug to function. Finding sometimes just as sedatives. Their effects range from secobarbital (Seconal). These drugs are sold in capsules and using the drug becomes the main focus in life. calming down anxious people to promoting sleep. Both and tablets or sometimes in a liquid form or tranquilizers and sleeping pills can have either effect, suppositories. depending on how much is taken. At high doses or Is it true that combining sedative- when they are abused, many of these drugs can even hypnotics with alcohol is especially What are the effects of barbiturates cause unconsciousness and death. dangerous? when they are abused? What are some of the sedative- Yes. Taken together, alcohol and sedative-hypnotics can The effects of barbiturates are, in many ways, similar to kill. The use of barbiturates and other sedative- the effects of alcohol. Small amounts produce calmness hypnotics? hypnotics with other drugs that slow down the body, and relax muscles. Somewhat larger doses can cause Barbiturates and benzodiazepines are the two major such as alcohol, multiplies their effects and greatly slurred speech, staggering gait, poor judgment, and slow, categories of sedative-hypnotics.
    [Show full text]
  • Newer Agents for the Anesthesiologist Paul R
    Henry Ford Hospital Medical Journal Volume 4 | Number 1 Article 3 3-1956 Newer Agents For The Anesthesiologist Paul R. Dumke Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Anesthesiology Commons, Life Sciences Commons, and the Public Health Commons Recommended Citation Dumke, Paul R. (1956) "Newer Agents For The Anesthesiologist," Henry Ford Hospital Medical Bulletin : Vol. 4 : No. 1 , 5-11. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol4/iss1/3 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. NEWER AGENTS FOR THE ANESTHESIOLOGIST* PAUL R. DUMKE, M.D.** At the time man began to look for agents which would produce pain relief and allow surgical procedures to be painless, he also became interested in methods of administering these agents. As we see our patients preoperatively most of them usually have two requests. First, they want to be "asleep" and second they want this "sleep" to be produced by an intravenous agent. Many specifically ask for pentothal. Some medical historians are already calling this present period "The Era of Intravenous Anesthesia."' We have been interested in finding the safest anesthetic agent for the patient; one which gives the surgeon the best operative conditions and still is pleasant for induction and has no after effects. To date, no one agent meets these criterion. Needless to say, the perfection of an anesthesia does not lie in a drug alone.
    [Show full text]
  • Management of Poisoning
    Management of Poisoning MOH Clinical Practice Guidelines Dec/2011 Health Ministry of Sciences Chapter of Emergency College of College of Family Manpower Authority Physicians Physicians, Physicians Academy of Medicine, Singapore Singapore Singapore Ministry of Health, Singapore College of Medicine Building 16 College Road Singapore 169854 Singapore Medical Pharmaceutical Society Society for Emergency Toxicology Singapore Paediatric TEL (65) 6325 9220 Association of Singapore Medicine in Singapore Society (Singapore) Society FAX (65) 6224 1677 WEB www.moh.gov.sg ISBN 978-981-08-9904-2 December 2011 Levels of evidence and grades of recommendation Levels of evidence Level Type of Evidence 1+ + High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias 1+ Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias 1- Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias 2+ + High quality systematic reviews of case control or cohort studies. High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal 2+ Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal 2- Case control or cohort studies with a high risk of confounding or bias and a signifi cant risk that the relationship is not causal 3 Non-analytic studies, e.g. case reports, case series 4 Expert opinion
    [Show full text]
  • Common Treatment Guidelines
    Lee County Common Treatment Guidelines Rewrite Date: 04/2016 Current Revision Date: 04/2018 Section 100 Section 100 – Forward Forward Table of Contents 2018 Section 100 – Forward • 100.01: Table of Contents • 100.02: Annotated Updates • 100.03: Intent & Usage • 100.04: Transfer of Care Memorandum of Understanding Section 200 – Clinical Guidelines General (200.--) • 200.01: Universal Care • 200.02: Patient Safety • 200.03: Airway | Ventilation | Oxygenation Management • 200.04: Pain | Anxiety | Procedural Sedation Management • 200.05: Nausea | Vomiting Management • 200.06: Patient Restraint • 200.07: Transport Destinations | Specialty Care Centers & Freestanding Emergency Departments • 200.08: Air Medical Transport • 200.09: Refusal of Care • 200.10: Death in the Field • 200.11: Mass Casualty Incident Triage | START & JumpSTART • 200.12: Emergency Services Personnel Rehabilitation • 200.13: Lee County School District Accident Waiver CardioPulmonary Arrest (210.--) • 210.01: AHA Adult BLS Healthcare Provider Algorithm 210.02: AHA Pediatric BLS Healthcare Provider Algorithm • 210.03: AHA Adult Cardiac Arrest Circular Algorithm • 210.04: AHA Adult Cardiac Arrest Algorithm • 210.05: AHA Maternal Cardiac Arrest Algorithm 210.06: AHA Pediatric Cardiac Arrest Algorithm 210.07: AHA Neonatal Cardiac Arrest Algorithm • 210.08: AHA Adult Immediate Post-Cardiac Arrest Care Algorithm 210.09: AHA Pediatric Immediate Post-Cardiac Arrest Care Algorithm • 210.10: Lee County Pit Crew Resuscitation Model 210.11: Lee County Pediatric Pit Crew Resuscitation
    [Show full text]